Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4565
|
pubmed:dateCreated |
1982-10-12
|
pubmed:abstractText |
Herpes simplex virus (HSV) exists in humans in a latent form that can be activated. To characterize the molecular basis of the cell-virus interactions and to analyze the state of the latent HSV genome, an in vitro model system was established. In this system a large fraction of the latently infected cells contain an HSV genome that can be activated. Cell survival was reduced minimally after repression of high multiplicity HSV type 1 (HSV-1) infection of human fibroblast cells with (E)-5-(2-bromovinyl)-2'-deoxyuridine in combination with human leukocyte interferon (IFN-alpha). A minimum of 1 to 3 percent of the surviving cells contained an HSV genome that could be activated either by human cytomegalovirus superinfection or reduction in incubation temperature.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0036-8075
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
217
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1145-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6180477-Bromodeoxyuridine,
pubmed-meshheading:6180477-Cells, Cultured,
pubmed-meshheading:6180477-Cytarabine,
pubmed-meshheading:6180477-Herpes Simplex,
pubmed-meshheading:6180477-Humans,
pubmed-meshheading:6180477-Interferons,
pubmed-meshheading:6180477-Simplexvirus,
pubmed-meshheading:6180477-Virus Activation,
pubmed-meshheading:6180477-Virus Replication
|
pubmed:year |
1982
|
pubmed:articleTitle |
High efficiency latency and activation of herpes simplex virus in human cells.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|